(Deadline: June 4, 2021)
*** For complete instructions, download the complete Request for Proposals (PDF) at the bottom of this page ***
Background
The current Request for Proposal (RFP) provides the details to apply for the McGill Regenerative Medicine Network (MRM) - McGill Interdisciplinary Initiative in Infection and Immunity (MI4) Collaborative Seed Fund Grant (SFG) competition.
This grant will support a new health research project focusing on stem cell or regenerative medicine within the domains of either infection or immunity. The MRM-MI4 SFG aims to catalyze innovative and impactful research at McGill and its affiliated hospitals, by providing initial funding to help position a new project to become competitive for sustained external funding. This opportunity provides one-time funding of up to $50,000 for a 12-month project.
Key Dates:
- Launch of MRM-MI4 SFG: May 4, 2021
- SFG application deadline: June 4, 2021, 11:59 PM Eastern Daylight Time
- Evaluation period: June 5, 2021 to June 30, 2021 (TBC)
- SFG announcement to applicants: July 2021 (date TBC)
Scope
The MRM-MI4 SFG supports innovative approaches that will provide answers within a 12-month timeframe. These projects should focus on infection or immunity AND stem cell or regenerative medicine.
Eligibility
The Principal Investigator must meet the conditions of University Researcher or Clinical University Researcher as defined by the Fonds de Recherche du Québec (frqs-generales-communes). In accordance with McGill policies, a researcher devotes more than 50% of their time to research and teaching.
The Principal Investigator must hold a McGill appointment.
Team Composition
The MRM-MI4 SFG can be held at any McGill University Department or McGill University-affiliated Research institute. An investigator’s location is defined as the primary location where their research team is located. The inclusion of other McGill community investigators as collaborators is encouraged, but only one Principal Investigator is permitted. The Principal Investigator or one of the designated collaborators must be a member of the McGill Regenerative Medicine Network. Investigators external to the McGill community are welcome to join the project team as collaborators, but may not be Principal Investigators.
Available Funds and Grant Term
One award is available up to a maximum of $50,000 in value. All funds will be disbursed in one payment at the start of the project. The grant term is 12 months. The MRM-MI4 SFG award is non-renewable and unspent funds must be returned to the source from which the funds originated (either MRM or MI4) at the end of this period.
Submission Deadline
The deadline for submissions is June 4, 2021 at 11:59 PM Eastern Daylight Time.
Instructions for Submission
For instructions for submission, please download the Request for Proposals (PDF) via the below link.
Contact
If additional information is required to complete the MRM-MI4 SFG submission, please contact mrm.coordinator [at] mcgill.ca or admincoordmcgilli4.med [at] mcgill.ca. Generally, a response will be provided within one business day.
